NCT06058377 2026-03-18
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
11 trialsNCT06632977 2026-03-04
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT05694559 2026-02-19
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT06569316 2026-01-29
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
Mayo Clinic
Phase NA Recruiting
NCT04494945 2026-01-23
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
NCT06630104 2026-01-08
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Mayo Clinic
Phase NA Recruiting
NCT04763980 2025-12-31
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
University of California, San Francisco
Phase NA Recruiting
NCT05649072 2025-11-19
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT04475640 2025-10-30
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Phase NA Recruiting
NCT06363162 2024-04-12
Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
Beijing Tiantan Hospital
Phase NA Recruiting